Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Decreases By 25.0%

Sysmex Co. (OTCMKTS:SSMXY) was the recipient of a significant decline in short interest in February. As of February 28th, there was short interest totalling 3,000 shares, a decline of 25.0% from the February 13th total of 4,000 shares. Based on an average trading volume of 112,900 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are short sold.

Sysmex Stock Up 2.0 %

Shares of Sysmex stock opened at $19.32 on Friday. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.19 and a quick ratio of 2.42. The stock has a market cap of $12.16 billion, a price-to-earnings ratio of 35.86 and a beta of 0.88. The firm’s 50-day moving average is $18.47 and its two-hundred day moving average is $19.10. Sysmex has a 1 year low of $14.38 and a 1 year high of $28.41.

Sysmex (OTCMKTS:SSMXY) last released its quarterly earnings data on Wednesday, February 12th. The company reported $0.17 earnings per share (EPS) for the quarter. As a group, research analysts expect that Sysmex will post 0.57 earnings per share for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.